Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Dutasteride and Testosterone Interaction: Avoid | Peptide Database

Compound Profiles Dutasteride Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, whi

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Dutasteride

Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH

Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.

Testosterone

Anabolic-Androgenic Steroid | Primary Male Sex Hormone

Testosterone exerts its effects primarily through binding to the intracellular androgen receptor (AR), forming a hormone-receptor complex that translocates to the nucleus and modulates gene transcription. This drives protein synthesis in skeletal muscle (anabolic effect), stimulates erythropoietin production in the kidneys to increase red blood cell mass, promotes osteoblast activity and bone mineral density, and regulates libido and cognitive function.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Dutasteride with Testosterone?

Combining Dutasteride with Testosterone is not recommended. Both Dutasteride and Testosterone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Dutasteride and Testosterone safe together?

This combination carries significant risk. Both Dutasteride and Testosterone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Dutasteride and Testosterone?

Both Dutasteride and Testosterone carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Dutasteride and Testosterone?

Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months) and Testosterone has a half-life of ~8 days (cypionate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
comparison

What's the dose range for cognitive enhancement versus being too much?

The cognitive 'sweet spot' is 0.5-2 mg/kg body weight (roughly 35-140 mg for a 70 kg person). Doses above 2 mg/kg often shift from antioxidant to pro-oxidant effects, becoming counterproduc…

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Normalizes immunogram in elderly patients with impaired immunity. Restores immune function after infectious diseases. Helps normalize immunity after radiation and chemotherapy exposure. Increases stress resistance and reduces respiratory infections in athletes. Doubles expression of heat-shock protein gene HSPA1A. Inhibits proliferation of K-562 human erythromyelosis tumor cells.

Source: peptide-db.com ↗

Explicit Research Data

Over 850 interaction entries documented from published research, clinical guidelines, and established protocols. Each entry includes the interaction status (synergistic, compatible, monitor, avoid, or timing-required) and a specific note explaining why.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Fluoxymesterone is exclusively administered orally as a 17-alpha-alkylated steroid. Pharmaceutical tablets have been produced in 2 mg, 5 mg, and 10 mg doses. The 17-alpha-methylation provides oral bioavailability but makes halotestin one of the most hepatotoxic oral anabolic steroids available. Due to its extreme liver toxicity, cycles must be kept very short and liver support supplementation is considered essential. Medical - Hypogonadism (Historical) 5-20 mg/day Divided into 2-4 doses daily Oral Performance - Strength Peaking 10-20 mg/day Split into 2 doses (morning and 1-2 hours pre-training) Performance - Pre-Contest Hardening Split into 2 doses daily

Source: peptide-db.com ↗
Side effects

Common Side Effects

Nausea (very common during initiation; typically resolves with continued use) Drowsiness and somnolence (often taken at bedtime to manage this) Dizziness or lightheadedness Headache Insomnia (in some users, despite drowsiness being more typical) Orthostatic hypotension (feeling faint when standing up quickly)

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →